Aggregated News
The despair of wanting a child you are unable to produce naturally has led to a multi-billion dollar Assisted Reproduction Technology (ART) industry offering a plethora of reproductive choices resulting in tens of thousands of births a year in the U.S. It has also led to controversy and a campaign to ban it.
Michele Goodwin, director of the Center for Biotechnology and Global Health Policy, holds the Chancellor’s Chair at the University of California, Irvine with appointments at the School of Law, School of Public Health, and Department of Gender and Sexuality Studies.
These technologies provide a stunning candy store of options: a spectrum so vast in array, scope, and breadth as to make heads spin: in vitro fertilization, ova selling, cryopreservation of ova, womb renting [surrogacy], pre-implantation genetic diagnosis, embryo transfer, assisted hatching, intracytoplasmic sperm injection (ICSI) of ova, embryo grading, and more.
Producing children with the assistance of anonymous third parties, while increasingly popular and accepted for anyone who can afford it, remains controversial. Despite compassion for the unmet longing to be a parent, there...